This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sillajen Biotherapeutics, Inc., Sillajen, Inc.. Active years: 2018-2019.
Company Filing History:
2 out of 12 
2 out of 4 Years Active: 2018-2019
Title: The Innovative Contributions of Anne Moon
Introduction
Anne Moon is a prominent inventor based in San Francisco, CA. She has made significant strides in the field of biotechnology, particularly in cancer research. With a total of 2 patents, her work focuses on developing innovative methods for inducing tumor-specific immune responses.
Latest Patents
Anne Moon's latest patents include groundbreaking inventions related to cancer treatment. One of her patents is titled "Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus." This invention outlines methods and compositions for inducing a tumor-specific antibody-mediated complement-dependent cytotoxic response in animals with tumors. The administration of a replication-competent oncolytic virus is central to her approach, as it induces the production of antibodies that specifically target the tumor.
Career Highlights
Throughout her career, Anne has worked with notable companies such as Sillajen, Inc. and Sillajen Biotherapeutics, Inc. Her contributions to these organizations have been instrumental in advancing cancer therapies and improving patient outcomes.
Collaborations
Anne has collaborated with esteemed colleagues in her field, including David H. Kirn and John Cameron Bell. These partnerships have fostered innovation and have been crucial in the development of her patented technologies.
Conclusion
Anne Moon's work exemplifies the impact of innovative thinking in the realm of cancer research. Her patents and collaborations highlight her commitment to advancing medical science and improving therapeutic options for patients.